DPP4 and type 2 diabetes mellitus: Therefore, in patients with T2DM characterised with moderately elevated HbA1c levels taking sulphonylurea as monotherapy, it would be safer to reduce the sulphonylurea dose when a DPP-4 inhibitor is added on.